Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The neutralization potency of anti-SARS-CoV-2 therapeutic... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants
0
Authors
Efi Makdasi
26 more
Efi Makdasi
•
Anat Zvi
24 more
•
Ronit Rosenfeld
Published
July 9, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Genetics
Gene
Virology
Show all topics
DOI
10.1101/2021.04.01.438035
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Genetics
Gene
Virology
Show all topics
DOI
10.1101/2021.04.01.438035
License
CC-BY-NC-ND
Other Formats
PDF
